Satisfaction Survey for the Outpatient Unit Dedicated to Post-cancer Treatment (BAC)

March 6, 2023 updated by: Groupe Hospitalier Paris Saint Joseph

The care pathway for breast cancer is complex, punctuated by consultations, complementary examinations and treatments. Patients benefit from close medical and paramedical support. At the end of the treatment, the post-cancer phase begins and the surveillance begins. The National Cancer Institute's (INCa) ten-year cancer control strategy for 2021-2030 defines in its second axis the objective of limiting the after-effects and improving the quality of life of cancer patients. Indeed, ensuring rapid access to functional rehabilitation and post-treatment reconstruction, and setting up personalized and graduated follow-up between the city and the hospital, are crucial. Better information for patients on the post-cancer period is a way for them to acquire greater autonomy, to enable them to take an active role in it and to approach it with greater serenity.

The Paris Saint-Joseph Hospital Group (GHPSJ) has therefore created an outpatient medical unit (UMAb) dedicated to post-cancer treatment in July 2021. It is offered to all patients who have had localized breast cancer and have received curative treatment. Each patient, 3-4 months after the end of treatment (surgery and/or chemotherapy and/or radiotherapy), will benefit from a half-day session including 3 consultations: medical, nursing and physiotherapy. The medical consultation allows for additional information if there are any questions about the care received, a clinical examination, reassessment of the tolerance of adjuvant hormone therapy if it is indicated, and delivery of the personalized post-cancer program (PPAC). The nursing consultation is conducted by a person certified in therapeutic patient education. Numerous items are discussed, with the aim of identifying personal difficulties (financial, family or work-related, for example) that may hinder post-cancer rehabilitation, detecting specific support care needs and promoting post-cancer health (encouraging normal weight, smoking cessation, recommended nutritional factors and physical activity). Finally, the physical therapy consultation consists of a joint, muscle and scar assessment to promote normal functionality and the implementation of recommended physical activity. Imaging examinations (cardiac ultrasound and/or mammography/ultrasound and/or bone densitometry) may be associated with the consultation.

As part of investigator's quality and continuous improvement approach, investigators would like to collect the opinions of patients who have benefited from the UMAb post breast cancer since its creation.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

163

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

France
- - Paris, France, 75014
    - Groupe Hospitalier Paris Saint-Joseph

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Patient whose age is ≥ 18 years, who has participated in post-cancer UMAB for breast cancer

Description

Inclusion Criteria:

Patient whose age is ≥ 18 years
Patient who has participated in post-cancer UMAB for breast cancer
French-speaking patient

Exclusion Criteria:

Patient under guardianship or curatorship
Patient deprived of liberty
Patient under court protection
Patient objecting to the use of her data for this research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Satisfaction reported by patients regarding the implementation of UMAb post breast cancer Time Frame: Month 1	This outcome corresponds to the number of satisfied patients who felt a benefit after participating in UMAb post breast cancer, using the satisfaction questionnaire.	Month 1

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Improvement in the post-breast cancer AMU Time Frame: Month 1	This outcome corresponds to the patient expectations and areas for improvement in post-breast cancer UMAb.	Month 1
Profile of patients with lower post-cancer UMAb scores to optimize their management, with specific measures Time Frame: Monthe 1	This outcome corresponds to the characteristics of patients with lower post-cancer UMAb scores (Scale: Very dissatisfied, Dissatisfied, Neutral, Satisfied, Very satisfied).	Monthe 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Groupe Hospitalier Paris Saint Joseph

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 18, 2022

Primary Completion (Actual)

August 18, 2022

Study Completion (Actual)

March 6, 2023

Study Registration Dates

First Submitted

September 2, 2022

First Submitted That Met QC Criteria